Recruiting NA Covid19

New treatment option for Covid19

Official title Hyperbaric Oxygen Therapy for Post-COVID-19 Syndrome

ClinicalTrials.gov ID: NCT04647656

What this study is testing

What it's testing
Post-COVID-19 syndrome is an assembly of symptoms, following an infection with Coronavirus disease 2019 (COVID-19). The syndrome is characterized by cognitive impairment, fatigue, sleep disorders, smell and taste disorders, pain and more.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Age above 18 years
  • Reported post COVID-19 cognitive deterioration that effect quality of life and persist at least 3 months after confirmed infection.
  • Subject willing and able to read, understand and sign an informed consent

You likely can't join if

  • Inability to attend scheduled clinic visits and/or comply with the study protocol
  • History of traumatic brain injury (TBI) or any other non COVID brain pathology
  • Active malignancy
  • Substance use at baseline
  • Severe or unstable physical disorders or major cognitive deficits at baseline
  • HBOT for any reason prior to study enrolment
See the full eligibility criteria
Who can join
  • Age above 18 years
  • Reported post COVID-19 cognitive deterioration that effect quality of life and persist at least 3 months after confirmed infection.
  • Subject willing and able to read, understand and sign an informed consent
What rules you out
  • Inability to attend scheduled clinic visits and/or comply with the study protocol
  • History of traumatic brain injury (TBI) or any other non COVID brain pathology
  • Active malignancy
  • Substance use at baseline
  • Severe or unstable physical disorders or major cognitive deficits at baseline
  • HBOT for any reason prior to study enrolment
  • Chest pathology incompatible with pressure changes (including moderate to severe asthma)
  • Ear or Sinus pathology incompatible with pressure changes
  • An inability to perform an awake brain MRI
  • Active smoking

The study team makes the final eligibility decision.

Where it's taking place

  • Ẕerifin, Israel

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Ẕerifin, Israel. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.